P. Wen and S. Kesari, Malignant Gliomas in Adults, New England Journal of Medicine, vol.359, issue.5, pp.492-507, 2008.
DOI : 10.1056/NEJMra0708126

A. Yin, J. Cheng, X. Zhang, and B. Liu, The treatment of glioblastomas: A systematic update on clinical Phase III trials, Critical Reviews in Oncology/Hematology, vol.87, issue.3, pp.265-82, 2013.
DOI : 10.1016/j.critrevonc.2013.01.007

L. Gravendeel, M. Kouwenhoven, O. Gevaert, J. De-rooi, A. Stubbs et al., Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology, Cancer Research, vol.69, issue.23, pp.9065-72, 2009.
DOI : 10.1158/0008-5472.CAN-09-2307

R. Verhaak, K. Hoadley, E. Purdom, V. Wang, Y. Qi et al., Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, vol.17, issue.1, pp.98-110, 2010.
DOI : 10.1016/j.ccr.2009.12.020

C. Geisenberger, A. Mock, R. Warta, C. Rapp, C. Schwager et al., Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain, Acta Neuropathologica, vol.360, issue.Suppl 1, 2015.
DOI : 10.1056/NEJMoa0808710

H. Noushmehr, D. Weisenberger, K. Diefes, H. Phillips, K. Pujara et al., Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma, Cancer Cell, vol.17, issue.5, pp.510-532, 2010.
DOI : 10.1016/j.ccr.2010.03.017
URL : https://hal.archives-ouvertes.fr/hal-01201573

C. Brennan, R. Verhaak, A. Mckenna, B. Campos, H. Noushmehr et al., The Somatic Genomic Landscape of Glioblastoma, Cell, vol.155, issue.2, pp.462-77, 2013.
DOI : 10.1016/j.cell.2013.09.034

M. Weller, S. Pfister, W. Wick, M. Hegi, G. Reifenberger et al., Molecular neuro-oncology in clinical practice: a new horizon, The Lancet Oncology, vol.14, issue.9, pp.370-379, 2013.
DOI : 10.1016/S1470-2045(13)70168-2

M. Esteller, Epigenetics in Cancer, New England Journal of Medicine, vol.358, issue.11, pp.1148-59, 2008.
DOI : 10.1056/NEJMra072067

M. Rodriguez-paredes and M. Esteller, Cancer epigenetics reaches mainstream oncology, Nature Medicine, vol.18, pp.330-339, 2011.
DOI : 10.1038/sj.leu.2403388

W. Timp, H. Bravo, O. Mcdonald, M. Goggins, C. Umbricht et al., Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors, Genome Medicine, vol.12, issue.8, p.61, 2014.
DOI : 10.1038/nrd4154

S. Baylin and P. Jones, A decade of exploring the cancer epigenome ??? biological and translational implications, Nature Reviews Cancer, vol.9, issue.16, pp.726-760, 2011.
DOI : 10.1038/nrg2270

B. Malzkorn, M. Wolter, M. Riemenschneider, and G. Reifenberger, Unraveling the Glioma Epigenome-From Molecular Mechanisms to Novel Biomarkers and Therapeutic Targets, Brain Pathology, vol.102, issue.2, pp.619-651, 2011.
DOI : 10.1042/BC20100029

H. Heyn and M. Esteller, DNA methylation profiling in the clinic: applications and challenges, Nature Reviews Genetics, vol.20, issue.10, pp.679-92, 2012.
DOI : 10.1186/1476-4598-9-259

A. Etcheverry, M. Aubry, M. De-tayrac, E. Vauleon, R. Boniface et al., DNA methylation in glioblastoma: impact on gene expression and clinical outcome., BMC Genomics, vol.11, issue.1, p.701, 2010.
DOI : 10.1186/1471-2164-11-701
URL : https://hal.archives-ouvertes.fr/inserm-00663706

R. Lai, Y. Chen, X. Guan, D. Nousome, C. Sharma et al., Genome-Wide Methylation Analyses in Glioblastoma Multiforme, PLoS ONE, vol.40, issue.2, p.89376, 2014.
DOI : 10.1371/journal.pone.0089376.s006

D. Sturm, H. Witt, V. Hovestadt, D. Khuong-quang, D. Jones et al., Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma, Cancer Cell, vol.22, issue.4, pp.425-462, 2012.
DOI : 10.1016/j.ccr.2012.08.024

A. Murat, E. Migliavacca, T. Gorlia, W. Lambiv, T. Shay et al., Stem Cell???Related ???Self-Renewal??? Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma, Journal of Clinical Oncology, vol.26, issue.18, pp.3015-3039, 2008.
DOI : 10.1200/JCO.2007.15.7164

S. Kurscheid, P. Bady, D. Sciuscio, I. Samarzija, T. Shay et al., Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma, Genome Biology, vol.16, issue.1, p.16, 2015.
DOI : 10.1038/nature07385

J. Cahoy, B. Emery, A. Kaushal, L. Foo, J. Zamanian et al., A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function, Journal of Neuroscience, vol.28, issue.1, pp.264-78, 2008.
DOI : 10.1523/JNEUROSCI.4178-07.2008

M. Oldham, G. Konopka, K. Iwamoto, P. Langfelder, T. Kato et al., Functional organization of the transcriptome in human brain, Nature Neuroscience, vol.24, issue.11, pp.1271-82, 2008.
DOI : 10.1038/nn.2207

N. Kane, A. Thrasher, G. Angelini, and C. Emanueli, Concise Review: MicroRNAs as Modulators of Stem Cells and Angiogenesis, STEM CELLS, vol.59, issue.5, pp.1059-66, 2014.
DOI : 10.1016/j.jacc.2012.02.033

W. Kong, L. He, E. Richards, S. Challa, C. Xu et al., Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer, Oncogene, vol.1, issue.6, pp.679-89, 2014.
DOI : 10.1038/nprot.2006.47

U. Maachani, A. Tandle, U. Shankavaram, T. Kramp, and K. Camphausen, Modulation of miR-21 signaling by MPS1 in human glioblastoma, Oncotarget, vol.7, issue.33, pp.52912-52927, 2015.
DOI : 10.18632/oncotarget.4143

X. Wang, J. Li, K. Dong, F. Lin, M. Long et al., Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia, Cellular Signalling, vol.27, issue.3, pp.443-52, 2015.
DOI : 10.1016/j.cellsig.2014.12.003

S. Ma, M. Liu, Z. Xu, Y. Li, H. Guo et al., A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 <i>versus</i> M2 macrophage polarization and thus regulates cancer progression, Oncotarget, vol.7, issue.12, pp.13502-13521, 2016.
DOI : 10.18632/oncotarget.6284

S. Yoon, E. Kim, M. Lee, W. Jung, H. Lee et al., <i>NOVA1</i> inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal, Oncotarget, vol.7, issue.3, pp.2475-95, 2016.
DOI : 10.18632/oncotarget.6542

X. Agirre, A. Vilas-zornoza, A. Jimenez-velasco, J. Martin-subero, L. Cordeu et al., Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia, Cancer Research, vol.69, issue.10, pp.4443-53, 2009.
DOI : 10.1158/0008-5472.CAN-08-4025

X. Liu, M. Chopp, R. Zhang, T. Tao, X. Wang et al., MicroRNA Profiling in Subventricular Zone after Stroke: MiR-124a Regulates Proliferation of Neural Progenitor Cells through Notch Signaling Pathway, PLoS ONE, vol.282, issue.5, p.23461, 2011.
DOI : 10.1371/journal.pone.0023461.s004

J. Dugas, T. Cuellar, A. Scholze, B. Ason, I. A. Emery et al., Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination, Neuron, vol.65, issue.5, pp.597-611, 2010.
DOI : 10.1016/j.neuron.2010.01.027
URL : https://doi.org/10.1016/j.neuron.2010.01.027

M. Gilbert, J. Dignam, T. Armstrong, J. Wefel, D. Blumenthal et al., A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma, New England Journal of Medicine, vol.370, issue.8, pp.699-708, 2014.
DOI : 10.1056/NEJMoa1308573

O. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus Radiotherapy???Temozolomide for Newly Diagnosed Glioblastoma, New England Journal of Medicine, vol.370, issue.8, pp.709-731, 2014.
DOI : 10.1056/NEJMoa1308345
URL : http://umu.diva-portal.org/smash/get/diva2:725879/FULLTEXT01

J. Issa, DNA Methylation As a Clinical Marker in Oncology, Journal of Clinical Oncology, vol.30, issue.20, pp.2566-2574, 2012.
DOI : 10.1200/JCO.2012.42.1016

J. Roessler, O. Ammerpohl, J. Gutwein, B. Hasemeier, S. Anwar et al., Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc., BMC Research Notes, vol.5, issue.1, p.210, 2012.
DOI : 10.1002/path.2495

M. Ehrlich, DNA hypomethylation in cancer cells, Epigenomics, vol.94, issue.2, pp.239-59, 2009.
DOI : 10.1073/pnas.94.9.4681

H. Han, C. Cortez, X. Yang, P. Nichols, P. Jones et al., DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter, Human Molecular Genetics, vol.2, issue.22, pp.4299-310, 2011.
DOI : 10.1371/journal.pgen.0020160

B. Berman, D. Weisenberger, J. Aman, T. Hinoue, Z. Ramjan et al., Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina???associated domains, Nature Genetics, vol.12, issue.1, pp.40-46, 2012.
DOI : 10.1186/gb-2009-10-7-r79

A. Franceschini, D. Szklarczyk, S. Frankild, M. Kuhn, M. Simonovic et al., STRING v9.1: protein-protein interaction networks, with increased coverage and integration, Nucleic Acids Research, vol.37, issue.D1, pp.808-823, 2013.
DOI : 10.1093/nar/gkn750

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-96, 2005.
DOI : 10.1056/NEJMoa043330

A. Teschendorff, F. Marabita, M. Lechner, T. Bartlett, J. Tegner et al., A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data, Bioinformatics, vol.24, issue.2, pp.189-96, 2013.
DOI : 10.1186/1471-2105-13-59

S. Madhavan, J. Zenklusen, Y. Kotliarov, H. Sahni, H. Fine et al., Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research, Molecular Cancer Research, vol.7, issue.2, pp.157-67, 2009.
DOI : 10.1158/1541-7786.MCR-08-0435
URL : http://mcr.aacrjournals.org/content/molcanres/7/2/157.full.pdf

W. Johnson, C. Li, and A. Rabinovic, Adjusting batch effects in microarray expression data using empirical Bayes methods, Biostatistics, vol.30, issue.4, pp.118-145, 2007.
DOI : 10.1093/nar/30.4.e15

T. Hothorn and A. Zeileis, Generalized Maximally Selected Statistics, Biometrics, vol.69, issue.4, pp.1263-1272, 2008.
DOI : 10.1093/biomet/69.2.297
URL : http://epub.wu.ac.at/1252/1/document.pdf

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.19, issue.18, pp.15545-50, 2005.
DOI : 10.1093/bioinformatics/btg363

Y. Liu, D. Hayes, A. Nobel, and J. Marron, Statistical Significance of Clustering for High-Dimension, Low???Sample Size Data, Journal of the American Statistical Association, vol.103, issue.483, pp.1281-93, 2008.
DOI : 10.1198/016214508000000454

C. Mermel, S. Schumacher, B. Hill, M. Meyerson, R. Beroukhim et al., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biology, vol.12, issue.4, p.41, 2011.
DOI : 10.1214/aos/1176344136

M. Lawrence, P. Stojanov, P. Polak, G. Kryukov, K. Cibulskis et al., Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, vol.31, issue.7457, pp.214-222, 2013.
DOI : 10.1038/nbt.2514

P. Bady, D. Sciuscio, A. Diserens, J. Bloch, M. Van-den-bent et al., MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status, Acta Neuropathologica, vol.6, issue.4, pp.547-60, 2012.
DOI : 10.1371/journal.pone.0025451